Collplant Biotechnologies Ltd Share Price

NASDAQ: CLGN

Small Cap

$2.62

+0.04

(+1.50%)

as on September 18, 2025 at 1:28 am IST

$₹

Collplant Biotechnologies Ltd Stock Performance

as on September 18, 2025 at 1:28 am IST

Day's Low
Day's High
$2.56
Day's Price Range
$2.72
$2.62
2.29%
Downside
3.82%
Upside
52 Week's Low
52 Week's High
$1.31
52-Week Price Range
$5
$2.62
50.00%
Downside
90.84%
Upside

Collplant Biotechnologies Ltd share price movements today

Previous Close: $2.58
Open: $2.56
Volume: 204.5K
Day's Low - High: $2.56 - $2.72
52 Week Low - High: $1.31 - $5

Collplant Biotechnologies Ltd Historical Returns

1 Month Return: + 1.23 %
3 Month Return: + 65.46 %
1 Year Return: -46.81 %
3 Year Return: -68.05 %
5 Year Return: -68.01 %

Collplant Biotechnologies Ltd Stock Fundamentals & Key Indicators

Check Collplant Biotechnologies Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.8M

EPS (TTM)

-0.315

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-12.4M

Revenue (TTM)

2.4M

Profit Margin

0.00%

Return On Equity TTM

191079400.00%

Collplant Biotechnologies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Collplant Biotechnologies Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Collplant Biotechnologies Ltd	BUY	$32.8M	-68.01%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Collplant Biotechnologies Ltd Stock including INR - Dollar returns

The Collplant Biotechnologies Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Collplant Biotechnologies Ltd investment value today

Current value as on today

₹58,619

Returns

₹41,381

(-41.38%)

Returns from Collplant Biotechnologies Ltd Stock

₹45,979 (-45.98%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Collplant Biotechnologies Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Collplant Biotechnologies Ltd. Average target price of $11.56

Collplant Biotechnologies Ltd Share Price Target

Get share price movements and forecasts by analysts on Collplant Biotechnologies Ltd.

What analysts predicted

77.34%UPSIDE

Target Price

$11.56

Current Price

$2.62

Analyzed by

8 Analysts

Target

$11.56

Collplant Biotechnologies Ltd target price $11.56, a slight upside of 77.34% compared to current price of $2.62. According to 8 analysts rating.

Collplant Biotechnologies Ltd Stock's Interest Amongst Investors

Search interest for Collplant Biotechnologies Ltd Stock has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:40% versus previous 30 day period

Collplant Biotechnologies Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	10	0	0	0	0	0	0	2	0
Gross Profit	0	9	0	0	0	0	0	0	1	0
Operating Income	-3	5	-4	-5	-4	-4	-4	-3	-1	-3
EBITDA	-3	5	-4	-	-4	-4	-4	-3	-1	-2
Interest Expense	0	-	-	-	0	-	-	0	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	5	-4	-4	-4	-4	-4	-3	-1	-3
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-3	5	-4	-4	-4	-4	-4	-3	-1	-3
Net Profit Margin	-903.23%	56.58%	-10179.07%	-1568.23%	-4280.61%	-1690.76%	-108150.00%	-2364.63%	-70.66%	-1869.83%

Collplant Biotechnologies Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	0	0	4	2	6	15	0	10	0
Gross Profit	0	0	0	4	0	3	13	0	8	-1
Operating Income	-4	-7	-5	-4	-7	-5	0	-17	-7	-17
EBITDA	-4	-6	-5	-3	-7	-4	0	-16	-6	-16
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0	0	1	1	1
Income Before Tax	-4	-7	-6	-3	-11	-5	0	-16	-7	-16
Income Tax Expense	0	0	0	2	3	0	0	0	0	-
Net Income	-4	-7	-6	-6	-14	-5	0	-16	-7	-16
Net Profit Margin	0.00%	-9537.05%	-1260.84%	-130.50%	-634.04%	-94.64%	2.61%	-5603.01%	-64.05%	-3225.05%

Collplant Biotechnologies Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	5	-4	-17	-4	-4	-4	-3	-1	-3
Operating Cash Flow	-3	6	-2	-3	-3	-3	-3	-1	-2
Investing Cash Flow	0	0	-	0	0	0	0	0	0
Financing Cash Flow	0	0	-	0	-	-	-	-	3
Change in Cash	-4	6	-3	-3	-4	-3	-3	-1	0

Collplant Biotechnologies Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-6	-3	-11	-5	0	-16	-7	-16
Operating Cash Flow	-5	-5	-1	-5	-4	2	-13	-2	-14
Investing Cash Flow	0	0	0	-1	0	-31	28	-1	0
Financing Cash Flow	4	9	2	5	4	38	1	1	0
Change in Cash	0	4	0	-1	0	9	16	-3	-14

Global Institutional Holdings in Collplant Biotechnologies Ltd

Funds	Holdings
Parallel Advisors, LLC	0.03%

Insights on Collplant Biotechnologies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, CLGN stock has moved up by 75.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 184.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 113.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.05M → 179.0K (in $), with an average decrease of 91.3% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -1.45M → -3.34M (in $), with an average decrease of 130.5% per quarter

About Collplant Biotechnologies Ltd

collplant is a regenerative medicine company focused on 3d bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. our products are based on our rhcollagen (recombinant human collagen) that is produced with collplant’s proprietary plant based genetic engineering technology. our products address indications for diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. our flagship rhcollagen bioink product line is ideal for 3d bioprinting of tissues and organs, and our unique vergenix line of rhcollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. collplant is a public company listed on the tel aviv stock exchange and on nasdaq (clgn).

Organisation	Collplant Biotechnologies Ltd
Headquarters	Weizmann Science Park, Rehovot, Israel, 7670104
Industry	Health Technology
CEO	Mr. Yehiel Tal
E-voting on shares	Click here to vote

Key Management of Collplant Biotechnologies Ltd

Name	Title
Dr. Elana Gazal	Vice President of Research & Development
Prof. Oded Shoseyov	Founder & Chief Scientist
Ms. Hadas Dreiher Horowitz	Vice President of Human Resources
Mr. Yehiel Tal	CEO & Director
Mr. Eran Rotem CPA	Deputy CEO & CFO
Mr. Oren Fahimipoor	Vice President of Operations

FAQs

What is Collplant Biotechnologies Ltd share price today?

Collplant Biotechnologies Ltd share price today is $2.62 as on September 18, 2025 at 1:28 am IST at the close of the market. Collplant Biotechnologies Ltd share today touched a day high of $2.72 and a low of $2.56.

What is the 52 week high and 52 week low for Collplant Biotechnologies Ltd share?

Collplant Biotechnologies Ltd share touched a 52 week high of $5 on October 1, 2024 and a 52 week low of $1.31 on July 1, 2025. Collplant Biotechnologies Ltd stock price today i.e. September 18, 2025 at 1:28 am IST is closed at $2.62,which is 47.60% down from its 52 week high and 100.00% up from its 52 week low.

What is Collplant Biotechnologies Ltd's market capitalisation today?

Collplant Biotechnologies Ltd market capitalisation is $0.00T as on September 18, 2025 at 1:28 am IST.

How to invest in Collplant Biotechnologies Ltd Stock (CLGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Collplant Biotechnologies Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Collplant Biotechnologies Ltd Shares that will get you 0.5725 shares as per Collplant Biotechnologies Ltd share price of $2.62 per share as on September 18, 2025 at 1:28 am IST.

What is the minimum amount required to buy Collplant Biotechnologies Ltd Stock (CLGN) from India?

Indian investors can start investing in Collplant Biotechnologies Ltd (CLGN) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 11:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Collplant Biotechnologies Ltd stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 11:45 am IST). Based on Collplant Biotechnologies Ltd share’s latest price of $2.62 as on September 18, 2025 at 1:28 am IST, you will get 3.8168 shares of Collplant Biotechnologies Ltd. Learn more about fractional shares .

What are the returns that Collplant Biotechnologies Ltd has given to Indian investors in the last 5 years?

Collplant Biotechnologies Ltd stock has given -68.01% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?